Received: 14 June 2019
Accepted: 27 November 2019
First Online: 6 December 2019
Ethics approval and consent to participate
: This study was approved by the institutional review board of National Cancer Institute, Cairo University. The approval ID number is 201217120.3 and approval date is 12/2012.Written informed consent was taken from all subjects who participated.Consent for publicationAll patients included gave written informed consents to publish the data contained within this study.
: The authors declare that they have no competing interests.